In a new study, scientists discovered two FDA-approved cancer drugs that could also be effective at combatting one well-known ...

Washington University Medicine in St. Louis is conducting important research into treating early-onset Alzheimer's before ...

The Phase I placebo-controlled, randomised, double-blind study aims to assess the safety and tolerability of MNA-001 in ...

The device, developed in the U.S. by the Michigan-based Renew Bioscience medical technology company, focuses on restoring vascular health in the brain, improving blood flow and oxygenation. Impaired ...

A newly approved blood test can help rule out some cases based on the amount of amyloid in the brain. A neurology professor ...

Researchers have identified special immune cells in the brain that help slow Alzheimer’s. These microglia work to reduce inflammation and block the spread of harmful proteins. They appear to protect ...

They're just one-tenth the size of conventional antibodies, and have not been found in any other mammals, say scientists.

New research from the University of Virginia offers a breakthrough in understanding Alzheimer's, pinpointing the degradation ...

A new study offers a concrete, testable explanation for why Alzheimer’s patients often stop recognizing their loved ones.

The impact of Alzheimer’s Disease touches nearly all of us in some way. According to the Alzheimer’s Association, 1 in 9 ...

The anguish isn't over lost memories, but losing the people we love while still alive. The cruelest Alzheimer's symptom is ...

One of the most devastating moments for family members of a patient with Alzheimer's is when their loved one forgets who they ...